#mpnsm
LightNews LightNews
vjhemonc.bsky.social
We recently spoke with Pankit Vachhani, who discussed the potential of MDM2 inhibitors for treating MPNs, outlining the encouraging results observed to date with the MDM2 inhibitor navtemadlin.

Click here to watch:

🎥 buff.ly/cBf3tFe

#MPNsm #HemOnc #BloodSky #HemeSky #MedSky
October 7, 2025 at 12:02 PM
onclive.bsky.social
The @fda.gov Approves Treosulfan for alloHCT Conditioning in AML and MDS #leusm #mpnsm #oncology
www.onclive.com/view/fda-app...
FDA Approves Treosulfan for alloHCT Conditioning in AML and MDS
The FDA approved treosulfan plus fludarabine for alloHSCT conditioning in acute myeloid leukemia or myelodysplastic syndrome.
www.onclive.com
January 24, 2025 at 9:18 PM
karintourmente.bsky.social
Entendu sur @franceinter.fr : « Le corps est un traître » - Marc Dugain
#MPNsm
November 29, 2024 at 8:48 AM
vjhemonc.bsky.social
The MPN Workshop of the Carolinas aims to provide up-to-date information about the pathogenesis & management of MPNs to practicing clinicians & to foster discussion to improve outcomes for patients.🩸

Register for the in-person event or the webinar here:
👉 buff.ly/tiCjJPk

#MPNsm #HemOnc #BloodSky
July 21, 2025 at 3:06 PM
majorajay.bsky.social
Honorable mention #MajorPROsASH: splenic RT before allo MF @michaelsbinkley
- 10 pts, symptomatic splenomegaly➡️MPN-SAF TSS PRO
- D+90 post allo: sx splenomegaly better by 20 pts (MID is ~1.5-2 points)
Phenomenal example of PRO integration into early-phase trials. #ASH24 #mpnsm
December 8, 2024 at 5:33 PM
karintourmente.bsky.social
« C’est la panique ! » : privés de médicaments pendant longtemps, les patients contraints au système D -
Excellent article de ⁦@nicolasberrod.bsky.social avec le témoignage de Pierre un adhérent de @vivreavecunenmp.bsky.social
⁩
#MPNsm ⁦@ansm-gouv.bsky.social
www.leparisien.fr/societe/sant...
⁩
« C’est la panique ! » : privés de médicaments pendant longtemps, les patients contraints au système D
Des centaines de molécules sont en « tension », voire en « rupture de stock » et cela peut durer plusieurs mois, confirme un rapport paru ce
www.leparisien.fr
March 29, 2025 at 11:19 AM
vjhemonc.bsky.social
What is the current role of T-cell engagers and CARs in myeloid malignancies?🩸

Find out by watching our exclusive expert discussion from #iwCART25 with David Sallman, Marion Subklewe, Jae Park, & Andrew Kuykendall here:

👉 buff.ly/mQBv32R

#AMLsm #Leusm #MPNsm #ImmunoOnc #HemeSky #BloodSky
May 15, 2025 at 3:04 PM
vjhemonc.bsky.social
#iwMPN25 | Alexander Lyon discusses cardiovascular health in patients with MPNs, and provides insight into risk stratification & management strategies.🫀🩸

Click here to watch the interview:

👉 buff.ly/CxamPIw 👈

#MPNsm #HemOnc #BloodSky #HemeSky #MedSky
July 23, 2025 at 8:01 AM
vjhemonc.bsky.social
Check out this week's podcast!🎙️

Featuring Marlise Luskin, Nicole LeBoeuf, and Shai Shimony, who share insights into BPDCN from a hematology and dermatology perspective.

🎧 Listen here: https://buff.ly/3ZxE0S6

#HemOnc #Leusm #MPNsm
December 2, 2024 at 12:35 PM
karintourmente.bsky.social
Moi quand je découvre que certaines institutions médicales se moquent royalement du point de vue des patients 🤬 :
#MPNsm
a girl with red hair and blue eyes is making a face
ALT: a girl with red hair and blue eyes is making a face
media.tenor.com
February 21, 2025 at 12:16 PM
vjhemonc.bsky.social
🎥 In a recent interview, the lovely Dr Jennifer O'Sullivan discussed cardiovascular safety and management of CV events when treating patients with JAK inhibitors, providing a UK perspective.

Click here to watch:
👉 buff.ly/SaGiSRO

#ESHCMLMPN2025 #MPNsm #HemOnc #BloodSky #HemeSky #MedSky
April 10, 2025 at 10:00 AM
vjhemonc.bsky.social
What is the MPN Workshop of the Carolinas, and why should you register?🤔🩸

Hear from course director @rubenmesamd.bsky.social as he invites you to attend this fantastic event in-person or virtually on August 22-23:

🎥 buff.ly/4Ja8SF6

Click below to register:
🔗 buff.ly/CTlggp7

#MPNsm #HemOnc
July 31, 2025 at 2:00 PM
vjhemonc.bsky.social
"70% of patients with advanced systemic #Mastocytosis will have an SM component and an AHN component."

Hear as Deepti Radia discusses the diagnosis & management of SM with an associated hematologic neoplasm (AHN):

🎥 buff.ly/IjFJWyr

#MPNsm #HemOnc #EBMT25 #BloodSky #HemeSky #MedSky
May 1, 2025 at 12:02 PM
onclive.bsky.social
.@mdanderson.bsky.social Study Resumes With Seclidemstat/Azacitidine in MDS/CMML #mpnsm #leusm #oncology www.onclive.com/view/md-ande...
MD Anderson Study Resumes With Seclidemstat/Azacitidine in MDS/CMML
The combination of seclidemstat and azacitidine will resume study in a phase 1/2 trial in patients with MDS and CMML following a partial clinical hold.
www.onclive.com
February 7, 2025 at 5:12 PM
drkomanduri.bsky.social
Hepcidin is a naturally occurring peptide hormone and a key regulator of iron trafficking in the body. Not all natural mimetics are equally safe but the toxicity profile of rusfertide does appear to be quite favorable. Would love if a classical hematologist with #mpnsm expertise would comment here.
June 9, 2025 at 12:07 AM
vjhemonc.bsky.social
The trial of INCA33989, a mutCALR-specific monoclonal antibody, in #EssentialThrombocythemia generated plenty of excitement at the #EHA2025 meeting last week!🩸

Hear the details from John Mascarenhas:

👉 buff.ly/DyV3HNd 👈

#MPNsm #TrialUpdate #CTSM #BloodSky #HemeSky #ImmunoOnc #MedSky
June 17, 2025 at 4:02 PM
nicogagelmann.bsky.social
🎉Finally out🎉

Clinical and Immune Effects of Peri-Transplantation JAK Inhibition for Myelofibrosis in Am J Hematol

👉using JAK inhibitors until engraftment is safe
👉 improved efficacy signals (excellent engraftment, reduced acute GVHD)
onlinelibrary.wiley.com/doi/full/10....
#mpnsm #medsky
November 18, 2024 at 7:07 AM
alexrampotas.bsky.social
Amazing presentation by Camelia Benlabiod (@beth_psaila / Caroline Marty lab) on the biology of calreticulin driven myelofibrosis in an immunocompetent mouse model #ASH24 #MPNsm
December 9, 2024 at 7:03 PM
mtmdphd.bsky.social
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR ow.ly/wC8F50IgpjR #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
February 3, 2025 at 12:26 AM
vjhemonc.bsky.social
🎧Tune in to our latest podcast episode to hear highlights from #iwMPN25!

Leading experts cover:
🩸Novel approaches for the upfront management of #myelofibrosis
🩸CV health in MPNs
🩸AI in the MDS/MPN setting

Listen now: 👉 buff.ly/HCMB4at

#MPNsm #HemOnc #BloodSky #HemeSky #MedSky
August 6, 2025 at 1:01 PM
vjhemonc.bsky.social
Watch our interview from the #MPNWorkshop25 with John Mascarenhas to learn about the potential of telomerase inhibition in MPNs, with a focus on imetelstat, which is being investigated in R/R #myelofibrosis:

👉 buff.ly/naSdbGl 👈

#MPNsm #CTSM #HemOnc #BloodSky #HemeSky #MedSky
August 29, 2025 at 4:42 PM
karintourmente.bsky.social
« Quelle maladie de merde ! » : ce sont les mots si justes de Mylène, en m’apprenant le décès de Nathalie, une jeune patiente NMP, suite à une greffe de moelle osseuse.
#MPNsm
December 30, 2024 at 2:06 PM
vjhemonc.bsky.social
AlloSCT in advanced systemic #mastocytosis: who, when, and how? 🤔

These were all questions the lovely Deepti Radia answered in an interview at the recent #EBMT25 meeting!

Watch here for her valuable insight:

👉 buff.ly/XOYpBvQ 👈

#MPNsm #HemOnc #BMTsm #MedSky #BloodSky #HemeSky
April 15, 2025 at 1:04 PM
kmirza.bsky.social
What story does this bone marrow tell you? #leusm #mdssm #mpnsm #hemepath
February 25, 2025 at 1:30 AM
vjhemonc.bsky.social
Have you had a chance to read our comprehensive feature article on moving beyond JAK inhibitor monotherapy in #myelofibrosis?🩸

Delve into the treatment options being explored and hear exclusive expert insights:

📖 👉 buff.ly/MN0SXef

#MPNsm #CTSM #TrialUpdate #HemOnc
April 24, 2025 at 3:04 PM